The management of patients on oral anticoagulation undergoing coronary stent implantation: a survey among interventional cardiologists from eight european countries
Journal of Interventional Cardiology,  Clinical Article

Rubboli A et al. – Among the 202 interventional cardiologists from the 8 European countries interviewed, the management of patients on oral anticoagulation (OAC) undergoing PCI–S appears variable and only partially adherent to currently available recommendations.

Methods
  • By means of a contact person who had been previously identified in 8 European countries, a questionnaire was electronically forwarded between April and July 2010 to the national institutions where PCI–S is performed.

Results
  • A total of 202 questionnaires (median response rate: 50%, range 33–78%) was received.
  • The prevalence of OAC patients among those undergoing PCI–S is mostly reported 5–10% (97%).
  • The peri–procedural pharmacological management mostly encompasses: preprocedural OAC interruption and bridging with low–molecular–weight heparin (59%), intraprocedural administration of an unfractionated heparin bolus (81%), and use of glycoprotein IIb/IIIa inhibitors on an individual basis (79%).
  • The radial approach is reported as the preferred option (58%), as well as the implantation of bare metal stents (76%).
  • Triple therapy (warfarin, aspirin, clopidogrel) is the most frequently prescribed (80%), generally for 1 month after bare metal stent (77%) and for at least 12 months after drug–eluting stent (60%).
  • Throughout triple therapy, the International Normalized Ratio is mostly targeted to the lower end of the therapeutic range (77%), and gastric protection is routinely prescribed (69%), mostly by giving proton–pump inhibitors (70%).

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Pharmacy

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pharmacy Articles

1 FDA approves new type of sleep drug, Belsomra Full Text FDA Press Announcements, August 14, 2014    Free full text

2 One injection stops diabetes in its tracks Salk Institute News, July 18, 2014

3 Antibiotic developed 50 years ago may be the key to fighting 'superbugs' University at Buffalo Health and Medicine News, June 19, 2014

4 FDA approves Afrezza to treat diabetes Full Text FDA Press Announcements, June 30, 2014    Free full text

5 Effect of ginger (Zingiber officinale) on heavy menstrual bleeding: a placebo-controlled, randomized clinical trial Phytotherapy Research, October 13, 2014    Clinical Article

6 Magnesium should be given to all children presenting to hospital with acute severe asthma Paediatric Respiratory Reviews, October 15, 2014    Clinical Article

7 New research indicates statin drugs must be taken properly Michigan State University Health News, July 22, 2014

8 Daily aspirin use and prostate cancer–specific mortality in a large cohort of men with nonmetastatic prostate cancer Journal of Clinical Oncology, October 24, 2014    Clinical Article

9 Buccal acetaminophen provides fast analgesia: two randomized clinical trials in healthy volunteers Full Text Drug Design, Development and Therapy, September 30, 2014    Free full text    Clinical Article

10 Duke team brings life-saving function to ketchup packets Duke University Health & Medicine News, July 3, 2014

11 Is the standard dose of amoxicillin-clavulanic acid sufficient? Full Text BMC Pharmacology & Toxicology, August 8, 2014    Free full text    Clinical Article

12 Honey as an effective antimicrobial treatment for chronic wounds Full Text Chronic Wound Care Management and Research, August 21, 2014    Free full text    Review Article

13 Honey: a potential therapeutic agent for managing diabetic wounds Full Text Evidence-based Complementary and Alternative Medicine , October 16, 2014    Free full text    Clinical Article

14 Differences in composition of honey samples and their impact on the antimicrobial activities against drug multiresistant bacteria and pathogenic fungi Archives of Medical Research, October 3, 2014    Clinical Article

15 “Worm pill” could ease autoimmune disease symptoms Monash University News, August 11, 2014

16 Update on recommendations for use of herpes zoster vaccine Full Text Morbidity and Mortality Weekly Report, August 22, 2014    Free full text

17 Levomilnacipran: A new serotonin-norepinephrine reuptake inhibitor for the treatment of major depressive disorder Annals of Pharmacotherapy, July 25, 2014    Review Article    Clinical Article

18 Effect of reiki therapy on pain and anxiety in adults: an in-depth literature review of randomized trials with effect size calculations Pain Management Nursing, October 2, 2014    Clinical Article

19 Dapoxetine for premature ejaculation: an updated meta-analysis of randomized controlled trials Clinical Therapeutics, October 29, 2014    Clinical Article

20 What's more effective: Generic or brand-name statins? Brigham and Women's Hospital, September 16, 2014

Indexed Journals in Pharmacy: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacistmore